The Filing Desk

Calumet

CLMT · Nasdaq · Energy · Financials, fiscal 2022 to 2025

CLMT · Last close · November 13, 2026
$34.30
Value Calumet yourself

Calumet's revenue fell 1.2% to $4.1 billion in fiscal 2025. Its operating margin was 2.6%, up from 0.2% a year earlier. Free cash flow was $57 million. The diluted share count rose 4.3%.

Calumet, Inc. /DE Latest fiscal year ended December 31, 2025 10-K filed February 27, 2026 · 0002013745-26-000007 Updated
Revenue
$4.1B
1.2%
Operating margin
2.6%
2.4 pts
Net income
−$34M
 
Free cash flow
$57M
 
Return on capital
6.2%
5.8 pts
Market cap
$3.0B
Nov 13 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Calumet does

Calumet makes specialty products and renewable fuels, and sells them to consumer and industrial customers across North America. It is based in Indianapolis, Indiana and runs twelve facilities. Its specialty products include solvents, waxes, lubricating oils, white oils, petrolatums and gels, which its customers use as raw materials for other products. It also sells high-performance motor oils and fuel products under the Royal Purple, Bel-Ray and TruFuel brands.

It reports three segments plus corporate costs. Specialty Products and Solutions makes and markets the specialty products. Performance Brands blends, packages and markets the branded products. Montana/Renewables has two plants: Montana Renewables turns renewable feedstocks into renewable diesel, sustainable aviation fuel and renewable naphtha, and a specialty asphalt plant turns Canadian crude oil into gasoline, diesel, jet fuel and specialty asphalt for local markets.

Calumet says the Montana/Renewables segment produced about 83.6% of its gross profit from continuing operations in 2025, and Specialty Products and Solutions about 40.6%. It says it passes higher feedstock costs on to its specialty products customers. It plans an expansion of the Montana Renewables plant.

Its biggest risks, as it describes them

  • Swings in the prices of crude oil and other commodities it buys and sells, which can narrow its margins.
  • Relying on outside pipelines to move its raw materials and products.
  • Accidents and shutdowns at its plants, including time out for maintenance, that cut revenue.
  • Strong competition in each of its markets.
  • Writing down the value of its plants or goodwill if they prove worth less than recorded.
From Calumet's annual report on Form 10-K, filed February 27, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

Calumet lost money in fiscal 2025: a net loss of $34 million.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red. Where the filings' structured data doesn't give a year's earnings per share, the column is blank.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY22FY23FY24FY25
Cash and short-term investments35838125
Debt incl. finance leases—1,8852,1212,235
Net debt (negative means net cash)—1,8782,0832,110
Net debt to EBITDA—4.5x13.3x8.2x
Debt to equity————
Interest coverage0.8x1.2x0.0x0.5x
Current ratio—0.7x0.9x1.0x
Quick ratio—0.3x0.4x0.6x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Calumet's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought Calumet shares on the open market, and 2 insiders sold $20.7 million, $267,381 of it under trading plans set up in advance.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Jul 1, 2026Daniel J SajkowskiDirectorSold plan4,240$36.16$153,318Form 4
May 15, 2026Heritage Group10% ownerSold626,998$32.54$20.4 millionForm 4
Apr 1, 2026Daniel J SajkowskiDirectorSold plan3,310$34.46$114,063Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score——5 of 9
Rule of 40−17.6%−2.7%0.1%
Altman Z''—−2.26−1.84
Accruals ratio—−6.4%−5.2%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positive—FailFail
Cash from operations is positiveFailFailPass
Return on assets rose——Pass
Cash from operations exceeds net incomeFailPassPass
Debt fell relative to assets——Fail
Current ratio rose—PassPass
Share count didn't riseFailFailFail
Gross margin rosePassFailPass
Revenue rose relative to assets——Fail
F-score——5 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Calumet side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
CalumetFY25−1.2%2.6%1.4%6.2%8.2x5
Delek USFY25−9.5%2.8%0.1%10.4%3.8x5Compare
Suncor EnergyFY25−4.6%——12.5%——Compare
EniFY25−7.5%6.1%5.6%3.3%1.6x—Compare
EquinorFY252.6%23.8%5.6%25.1%0.3x—Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

4 years of figures

Fiscal yearFY22FY23FY24FY25
Income statement
Revenue4,6864,1814,1894,137
Revenue growth—−10.8%0.2%−1.2%
Gross profit352452231246
Research and development————
Operating income1322678109
Net income−17348−222−34
Diluted EPS (US$)——−2.67−0.39
Diluted shares (millions)79808387
Cash flow
Cash from operations101−15−46109
Capital expenditure5362727752
Free cash flow−436−287−12357
Dividends paid0000
Share buybacks0000
Acquisitions0000
Stock-based compensation171515−4
Balance sheet at fiscal year end
Cash and short-term investments35838125
Debt incl. finance leases—1,8852,1212,235
Total assets—2,7512,7582,689
Total liabilities—2,9963,2243,176
Shareholders' equity−533−490−712−733
Margins and ratios
Gross margin7.5%10.8%5.5%5.9%
Operating margin2.8%6.4%0.2%2.6%
Net margin−3.7%1.1%−5.3%−0.8%
Free cash flow margin−9.3%−6.9%−2.9%1.4%
Rule of 40 (growth + FCF margin)—−17.6%−2.7%0.1%
Return on capital——0.5%6.2%
Return on equity————
Return on assets——−8.1%−1.2%
Net debt to EBITDA—4.5x13.3x8.2x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Calumet's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Calumet.